SCHEMBL4554499

SCHEMBL4554499

O=C(Nc1ccc(Cl)cc1)N(CCN(C(=O)Nc1ccc(Cl)cc1)c1ccccc1)c1ccccc1

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.60
USP2 O75604 1/20 0.60
KMT2A Q03164 3/20 0.59
MEN1 O00255 2/20 0.59
MAPT P10636 4/20 0.58
RAB9A P51151 4/20 0.58
ALDH1A1 P00352 3/20 0.58
SMN1; SMN2 Q16637 3/20 0.58
NPC1 O15118 3/20 0.58
ALOX15 P16050 1/20 0.58
THRB P10828 1/20 0.58
LMNA P02545 2/20 0.56
HTT P42858 2/20 0.53
GAA P10253 1/20 0.53
TSHR P16473 2/20 0.53
NPSR1 Q6W5P4 2/20 0.48
PKM P14618 1/20 0.47
CCR5 P51681 1/20 0.47
CNR1 P21554 1/20 0.47
EPHX2 P34913 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4548052 0.91 MEN1 (0.61) HSD17B10USP2KMT2AMEN1MAPT
SCHEMBL20016685 0.88 MEN1 (0.79) HSD17B10USP2KMT2AMEN1MAPT
SCHEMBL5819195 0.85 KMT2A (0.57) HSD17B10USP2KMT2AMEN1MAPT
SCHEMBL17932837 0.83 USP2 (0.63) HSD17B10USP2KMT2AMEN1MAPT
SCHEMBL9871496 0.81 RAB9A (0.63) HSD17B10KMT2AMEN1MAPTRAB9A
SCHEMBL10841580 0.80 MEN1 (0.68) HSD17B10USP2KMT2AMEN1MAPT
SCHEMBL27602815 0.79 NPC1 (0.59) HSD17B10KMT2AMEN1MAPTRAB9A
SCHEMBL11050841 0.79 TSHR (0.64) HSD17B10KMT2AMEN1MAPTRAB9A
SCHEMBL29200409 0.78 KMT2A (0.70) HSD17B10USP2KMT2AMEN1MAPT
SCHEMBL10412571 0.77 SMN1; SMN2 (0.54) HSD17B10KMT2AMEN1MAPTRAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9932300-B2 N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2018-04-03 US disclosed
US-20160318857-A1 N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation PRESIDENT AND FELLOWS OF HARVARD COLLEGE 2016-11-03 US disclosed
US-9421211-B2 N,N′-diarylurea compounds and N,N′-diarylthiourea compounds as inhibitors of translation initiation PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2016-08-23 US disclosed
US-20120115915-A1 N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2012-05-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20160318857-A1 N,N'-Diarylurea Compounds and N,N'-Diarylthiourea Compounds as Inhibitors of Translation Initiation NSUN2, EIF2AK2, RNGTT HSD17B10 3094/4885USP2 1701/4885KMT2A 761/4885
US-20120115915-A1 N,N'-DIARYLUREA COMPOUNDS AND N,N'-DIARYLTHIOUREA COMPOUNDS AS INHIBITORS OF TRANSLATION INITIATION NSUN2, EIF2AK2, RNGTT HSD17B10 3094/4885USP2 1701/4885KMT2A 761/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.